Irish pharmaceutical company Amarin sent a glowing announcement to investors Monday. CNN reports that its drug Vascepa, a purified fish oil derivative, was linked to a 25% reduced risk of major cardiovascular events such as heart attack and stroke.
While some doctors saw this announcement as a stunning and unexpected result that could change medical practice, others are reserving their judgment. This until the company shares its data, which have not been published in a peer-reviewed journal.
Dr.